CVS Health Corporation $CVS Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. increased its holdings in CVS Health Corporation (NYSE:CVS) by 4.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,364,203 shares of the pharmacy operator’s stock after purchasing an additional 53,048 shares during the period. Victory Capital Management Inc.’s holdings in CVS Health were worth $102,847,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Focus Partners Advisor Solutions LLC boosted its position in shares of CVS Health by 82.0% in the third quarter. Focus Partners Advisor Solutions LLC now owns 19,316 shares of the pharmacy operator’s stock worth $1,483,000 after acquiring an additional 8,703 shares during the last quarter. Kingsview Wealth Management LLC grew its stake in shares of CVS Health by 316.2% during the 3rd quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock valued at $7,873,000 after buying an additional 79,340 shares during the period. 111 Capital acquired a new position in CVS Health in the third quarter valued at $1,127,000. Elo Mutual Pension Insurance Co increased its stake in CVS Health by 21.6% during the third quarter. Elo Mutual Pension Insurance Co now owns 187,852 shares of the pharmacy operator’s stock worth $14,162,000 after acquiring an additional 33,376 shares during the last quarter. Finally, BCGM Wealth Management LLC lifted its stake in shares of CVS Health by 2.8% in the 3rd quarter. BCGM Wealth Management LLC now owns 28,020 shares of the pharmacy operator’s stock valued at $2,112,000 after purchasing an additional 757 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently commented on CVS. Bank of America cut their price target on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a report on Tuesday, January 27th. TD Cowen lifted their target price on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, December 10th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Barclays raised their price objective on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $91.00 target price on shares of CVS Health in a research report on Tuesday, January 6th. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $94.77.

CVS Health Stock Performance

NYSE:CVS opened at $80.57 on Thursday. The firm has a 50-day moving average of $78.53 and a two-hundred day moving average of $77.50. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The stock has a market cap of $102.50 billion, a P/E ratio of 58.38, a PEG ratio of 0.84 and a beta of 0.49. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. During the same quarter in the previous year, the firm posted $1.19 earnings per share. The company’s revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.